Rankings
▼
Calendar
NXTC Q3 2018 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena
NXTC
NextCure, Inc.
$35M
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$5M
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.57
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$90,000
← FY 2018
All Quarters
Q4 2018 →
